Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors

Stopped PI and Sponsor decision. Accrual was low and there was sufficient data to detect a response.

Conditions

• Primary Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Interventions

• DRUG: Selinexor

Sponsor

University of Utah

Collaborators

• [object Object]